We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Pipetting Robot Automates COVID-19 Testing Processes to Reduce Repetitive Work and Accidents

By LabMedica International staff writers
Posted on 24 Jun 2020
Print article
Image: Flowbot ONE (Photo courtesy of Flow Robotics)
Image: Flowbot ONE (Photo courtesy of Flow Robotics)
A new pipetting robot is automating COVID-19 testing processes in European hospitals, thereby significantly reducing the time taken by laboratories to generate results.

The liquid handling robot named flowbot ONE developed by Flow Robotics (Copenhagen, Denmark) makes automating pipetting simple with an intuitive user interface that can be mastered in just one hour. The company has termed flowbot ONE as a liquid handling cobot as it collaborates with the user in the lab, assisting in workflows and adapting to the lab. It does not require programming, extensive training, or a long implementation period. With flowbot ONE, these steps can be skipped and automation can be started immediately. The highly precise system ensures accurate and consistent pipetting and results, saving time as well as increasing safety by minimizing manual handling of pathogenic strains.

A plug and play solution with high accuracy and precision, flowbot ONE allows the user to customize components and liquid classes easily, edit, copy and share existing programs. It offers a range of functions to ease the workflow such as two pipette modules (choice between 1, 4 and 8-channel), volume ranges of 1-20μL, 2-200μL and 10-1000μL, 12 capacity positions (SBS format), and automatic liquid level detection. flowbot ONE has taken over the massive workload of COVID-19 sample preparation in hospitals across Europe.

“Our stress levels have decreased in many ways: less repetitive work, and fewer potential errors. While the robot is pipetting, we can perform other tasks, accelerating the speed of the COVID-19 tests we are performing,” said Martin Friis, a molecular biologist at Herlev Hospital.

Related Links:
Flow Robotics

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
SARS-CoV-2 Test
One Step SARS-CoV-2 Nucleic Acid Detection Kit (P761H)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more